Amphastar Pharmaceuticals, Inc. (AMPH) is the 37th largest of 92 Generic Drugs companies by market capitalisation, at 995.96 Mn, behind Maravai Lifesciences Holdings, Inc. at 1.04 Bn. It trades on a P/E of 11.94, 59% below the peer median of 29.44. The table below compares all 92 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.81 Bn | 61.51 | 2.47 | 39.16 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.23 Bn | -46.82 | 1.30 | 18.34 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.88 Bn | 782.82 | 2.70 | 9.71 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.53 Bn | 25.68 | 1.77 | 5.40 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -2.18 | 0.22 | 0.55 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -5.38 | 4.37 | 1.36 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 13.88 | 1.53 | 1.14 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 11.94 | 1.36 | 0.71 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -92.67 | 7.65 | 0.37 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -434.89 | 37.17 | 0.18 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -9.86 | 42.46 | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.72 | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.48 | 0.51 | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.77 | 0.21 | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.89 | 34.79 | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.24 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.59 | 1.78 | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.39 | 2.28 | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.26 | 0.04 | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 53.74 | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.94 Bn | 31.95 | 4.85 | 220.87 Bn |
| 25 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 184.62 Bn | 34.03 | 3.96 | 179.02 Bn |
| 26 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.83 Bn | 36.36 | 2.49 | 147.13 Bn |
| 27 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.42 Bn | 37.64 | 3.13 | 30.13 Bn |
| 28 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.61 Bn | 9.35 | 3.22 | 28.93 Bn |
| 29 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.93 Bn | 43.55 | 7.19 | 23.49 Bn |
| 30 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.51 Bn | 73.65 | 2.16 | 20.94 Bn |
| 31 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.17 Bn | 26.20 | 3.51 | 20.69 Bn |
| 32 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.32 Bn | -56.06 | 3.33 | 13.13 Bn |
| 33 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.82 Bn | 557.24 | 1.16 | 10.67 Bn |
| 34 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.29 Bn | 226.66 | 14.79 | 11.98 Bn |
| 35 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.75 Bn | 25.97 | 3.19 | 9.21 Bn |
| 36 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.24 Bn | -43.54 | 10.57 | 7.19 Bn |
| 37 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.61 Bn | 115.04 | 4.56 | 6.95 Bn |
| 38 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 39 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.57 Bn | 23.86 | 4.22 | 5.98 Bn |
| 40 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.46 | 1.21 | 6.05 Bn |
| 41 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.36 Bn | -44.80 | 2.47 | 5.52 Bn |
| 42 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.10 Bn | 44.05 | 13.54 | 5.82 Bn |
| 43 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.81 Bn | 29.44 | 19.98 | 4.45 Bn |
| 44 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 45 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.25 | 0.59 | 2.47 Bn |
| 46 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.15 Bn | 12.94 | 4.20 | 2.02 Bn |
| 47 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -6.49 | 3.89 | 0.89 Bn |
| 48 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | -186.21 | 905.74 | 1.56 Bn |
| 49 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.21 | 5.12 | 1.33 Bn |
| 50 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -171.81 | 0.76 | 0.97 Bn |
| 51 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | 7.48 | 3.08 | 1.09 Bn |
| 52 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.04 Bn | -7.61 | 4.96 | 0.97 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -15.14 | 22.95 | 0.76 Bn |
| 54 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.76 Bn |
| 55 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.14 | 375.99 | 0.84 Bn |
| 56 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.64 Bn | — | — | 0.22 Bn |
| 57 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.20 | 11.86 | 0.54 Bn |
| 58 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.58 | 2.41 | 0.35 Bn |
| 59 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -1.25 | 138.70 | 0.21 Bn |
| 60 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.31 Bn | 3.56 | 0.31 | 0.09 Bn |
| 61 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.70 | 3.41 | 0.14 Bn |
| 62 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.66 | 0.38 | 0.15 Bn |
| 63 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.06 | 1.54 | 0.14 Bn |
| 64 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,431.03 | 0.04 Bn |
| 65 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.54 | 6.16 | 0.14 Bn |
| 66 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -57.60 | 3.09 | 0.18 Bn |
| 67 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.51 | 108.13 | 0.15 Bn |
| 68 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.31 | 2.26 | 0.10 Bn |
| 69 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.27 | 1.69 | 0.08 Bn |
| 70 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -6.11 | 37.49 | 0.10 Bn |
| 71 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 72 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.63 | — | 0.07 Bn |
| 73 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.84 | 5.35 | 0.05 Bn |
| 74 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.42 | 1.44 | 0.03 Bn |
| 75 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.18 | -0.08 Bn |
| 76 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.19 | 0.97 | 0.02 Bn |
| 77 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.37 | 0.03 Bn |
| 78 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | -0.89 | 5.27 | 0.03 Bn |
| 79 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.68 | — | 0.03 Bn |
| 80 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.75 | 0.40 | 0.00 Bn |
| 81 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.87 | 17.28 | 0.01 Bn |
| 82 | HIND | Vyome Holdings, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.30 | 120.11 | 0.01 Bn |
| 83 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.85 | 0.09 | 0.00 Bn |
| 84 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.64 | 0.00 Bn |
| 85 | MGRX | Mangoceuticals, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 0.01 Bn | -0.43 | 21.96 | 0.01 Bn |
| 86 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 87 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.95 | 2.84 | 0.00 Bn |
| 88 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 89 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.64 | 10.82 | 0.00 Bn |
| 90 | SKVI | Skinvisible, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 91 | FCHS | First Choice Healthcare Solutions, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 92 | NXGLW | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.02 | 0.01 | 0.00 Bn |